CDT1
protein-codingchromatin licensing and DNA replication factor 1
Gene summary
The protein encoded by this gene is involved in the formation of the pre-replication complex that is necessary for DNA replication. The encoded protein can bind geminin, which prevents replication and may function to prevent this protein from initiating replication at inappropriate origins. Phosphorylation of this protein by cyclin A-dependent kinases results in degradation of the protein. [provided by RefSeq, Mar 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013431
Submitter: ClinGen
The CDT1 gene is located on chromosome 16 at 16q24.3 and encodes the chromatin licensing and DNA replication factor 1, a ubiquitously expressed protein which is required for pre-replication complex assembly. The CDT1 cooperates with the origin recognition complex (ORC) and CDC6 in recruiting mini-chromosome maintenance (MCM) complex to DNA to form pre-replication complexes and is also implicated in mitosis. The CDT1 gene was first reported in relation to autosomal recessive Meier-Gorlin syndrome 4 (MGS4) in 2011 (Bicknell et al. 2011 PMID 21358632; Guernsey et al. 2011 PMID 21358631). Meier-Gorlin syndrome (MGS) is characterized by a clinical triad of symptoms: short stature, microtia, and small or absent patellae. Additional features reported in individuals with MGS4 may include IUGR with failure to thrive, reduced body weight, respiratory issues, pulmonary emphysema, abnormal genitalia in males and mammary hypoplasia in females, musculoskeletal abnormalities, and dysmorphic facial features with small mouth, microretrognathia, and full lips, among other presentations (22333897: de Munnik et al. 2012). Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least nine unique variants have been found in either compound heterozygous (n=7) or homozygous (n=1) state in eight cases diagnosed with MGS from five reports in the literature (21358631; 21358632; Munnik et al., 2012 PMID 22333897; Kim et al. 2017 PMID 28425089; Knapp et al. 2020 PMID 33338304). These included four unique missense variants (one of which is is predicted to impact splicing), two nonsense variants, one frameshift variant, one intronic variant shown to affect splicing, and one in frame indel (removing 1 amino acid) variant. More genetic evidence has been reported in the literature but was not scorable according to the current guidelines (21358632; 28425089; Fitzgerald et al. 2015 PMID 25533962; Retterer et al. 2016 PMID 26633542). Experimental evidence includes data on biochemical function, functional alteration and a non-human model organism. A number of genes involved in pre-replication complex formation and function have been associated with Meier-Gorlin syndrome (MGS). Specifically, ORC1, ORC4, ORC6, CDC6, CDC45, MGM5, GMNN, and DONSON have all been associated with autosomal recessive MGS (33477564: Schmit and Bielinsky 2021). Patient-derived lymphoblastoid cell lines show impaired origin licensing capacity as shown through reduced episome replication (Stiff et al. 2013 PMID 23516378). Several biallelic Dup (CDT1-ortholog) loss-of-function Drosophila mutants are either embryonically lethal with some mutants showing a block in replication early in S phase, or present with defect in replication in ovaries of adult females (Whittaker et al. 2000 PMID 10898791). In summary, there is definitive evidence to support the relationship between CDT1 and autosomal recessive Meier-Gorlin syndrome 4. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0013431
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013431
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0016817
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CDT1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_030928.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 122 | 4 | 128 | ||
| missense | 2 | 2 | 239 | 30 | 3 | 276 |
| nonsense | 6 | 2 | 1 | 9 | ||
| start loss | 2 | 2 | ||||
| frameshift | 9 | 2 | 11 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | 6 | |||
| Total | 17 | 9 | 247 | 152 | 7 | 432 |
Highest pathogenic variant AF is 0.00011347599
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_112190.2 | 10 | MANE Select | |
| Ensembl | ENSP00000301019.4 | 10 | MANE Select | |
| Ensembl | ENSP00000456926.1 | 5 | Standard | |
| Ensembl | ENSP00000599844.1 | 10 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cdt1 | Danio rerio | Structure: cell Quality: increased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Mitotic G1-G1-S phases
- Retinoblastoma (RB) in Cancer
- DNA Replication
- cdk regulation of dna replication
- Activation of E2F1 target genes at G1/S
Biological Process
- DNA replication checkpoint
- G1/S transition of mitotic cell cycle
- regulation of transcription involved in G1/S transition of mitotic cell cycle
- mitotic cell cycle
- mitotic cytokinesis
Molecular Function
- DNA binding
- chromatin binding
- protein binding
- DNA polymerase binding
Cellular Component
- kinetochore
- condensed chromosome kinetochore
- nucleus
- nucleoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000301019
- Coding exons
- 10
- Length
- 6046
- Individuals with no LoFs
- 125422
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 65
- Defined
- 125487
- p
- 0.000259
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.90 | 435 | 337 | 1.29 | 0.0000245 | 3425 |
| Missense (PolyPhen) | 86 | 78.592 | 1.0943 | 799 | ||
| Synonymous | -2.81 | 190 | 147 | 1.30 | 0.0000105 | 1190 |
| Loss of Function | 0.806 | 17 | 21.0 | 0.810 | 0.00000109 | 229 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00064 | 0.00056 | rare |
| Latino/Admixed American | 0.000088 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0.00051 | 0.00051 | rare |
| European (Non-Finnish) | 0.00021 | 0.00020 | rare |
| South Asian | 0.00069 | 0.00049 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Required for both DNA replication and mitosis (PubMed:11125146, PubMed:22581055, PubMed:21856198, PubMed:14993212, PubMed:26842564). DNA replication licensing factor, required for pre-replication complex assembly. Cooperates with CDC6 and the origin recognition complex (ORC) during G1 phase of the cell cycle to promote the loading of the mini-chromosome maintenance (MCM) complex onto DNA to generate pre-replication complexes (pre-RC)(PubMed:14672932). Required also for mitosis by promoting stable kinetochore-microtubule attachments (PubMed:22581055). Potential oncogene (By similarity). {ECO:0000250|UniProtKB:Q8R4E9, ECO:0000269|PubMed:11125146, ECO:0000269|PubMed:14672932, ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22581055, ECO:0000269|PubMed:26842564}.;
- Disease
- DISEASE: Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]: A syndrome characterized by bilateral microtia, aplasia/hypoplasia of the patellae, and severe intrauterine and postnatal growth retardation with short stature and poor weight gain. Additional clinical findings include anomalies of cranial sutures, microcephaly, apparently low-set and simple ears, microstomia, full lips, highly arched or cleft palate, micrognathia, genitourinary tract anomalies, and various skeletal anomalies. While almost all cases have primordial dwarfism with substantial prenatal and postnatal growth retardation, not all cases have microcephaly, and microtia and absent/hypoplastic patella are absent in some. Despite the presence of microcephaly, intellect is usually normal. {ECO:0000269|PubMed:21358631, ECO:0000269|PubMed:21358632}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- LoFtool
- 0.757
- RVIS EVS
- 1.18
- RVIS percentile EVS
- 92.84
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.860
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |